Wales’ fastest growing indigenous business can be revealed as ALS Managed Services. The innovative recruitment and staffing solutions firm, which recently moved from Pontypool to Caerphilly, tops this year’s Wales Fast Growth project, which ranks the 50 fastest growing indigenous businesses based on revenue growth over the past two years. ALS Managed Services, which works with some of the largest recycling and warehousing companies in the UK, and was recently acquired in a management buyout led by chief executive Steve Langian, achieved a staggering revenue growth of 4,237.6%, between 2015-17 with sales up from £250,264 to £10.85m. The annual list, which celebrated its 20th anniversary this year, was started by Professor Dylan Jones-Evans. Prof Jones-Evans said: "Every year the list identifies some incredible businesses that are making a significant difference to their sectors, markets and communities, and that this year was no exception." The largest sector this … [Read more...] about Wales Fast Growth 50,2018: These are the fastest growing companies in Wales
Mid sized pharma companies
This article is part of the Global Policy Lab: Decoding Cancer. Genomics, it’s said, has the potential to turn every cancer into its own unique snowflake, to be tackled not with off-the-shelf treatments but a personalized regimen. That threatens to make the gold standard of drug testing, the randomized clinical trial, look a bit tarnished. Here are four ways cancer is changing the way we test drugs and treatments, from the perspective of industry, regulators, doctors, researchers and patients. Out-of-body In a typical drug trial, the manufacturer sends pills to patients, identical little capsules to be swallowed. Not so for personalized therapies like the prostate cancer treatment currently being tested by Sotio, a mid-sized biotech in the Czech Republic. Instead, patients’ blood samples are collected in more than 200 sites in more than 20 countries and then sent to Prague, where technicians re-engineer cells to fight their cancer and send them back to the … [Read more...] about 4 ways cancer is changing how we test medicines
Press play to listen to this article By FLORIAN EDERwith ZOYA SHEFTALOVICH PRESENTED BY GOOGLE Send tips here | Tweet @florianeder | Listen to today’s Playbook and view in your browser GOOD MORNING. Still not convinced that Jean-Claude Juncker’s soybean pact with Donald Trump was the real deal? Well, you don’t need to be, as long as Trump is. Today, the European Commission is expected to release the latest figures on imports of American soybeans. In short: Trade has never before been this great; numbers have never been this yuge. The figures, obtained by Playbook, show that in the 12 weeks from July, EU imports from the U.S. are up by 133 percent compared to last year, and the U.S. share of the EU’s total imports of soybeans is now at 52 percent, compared to 25 percent during the same period last year. This puts the States ahead of Brazil, Canada, Paraguay and Uruguay. **A message from Google: The Digital News Innovation … [Read more...] about POLITICO Brussels Playbook, presented by Google: Summit to talk about — Yes He Kern — Vestager’s sour grapes?
In the midst of the worst drug epidemic in American history, the U.S. Drug Enforcement Administration's ability to keep addictive opioids off U.S. streets was derailed, that according to Joe Rannazzisi, one of the most important whistleblowers ever interviewed by 60 Minutes. Rannazzisi ran the DEA's Office of Diversion Control, the division that regulates and investigates the pharmaceutical industry. As we first reported last October, in a joint investigation by 60 Minutes and The Washington Post, Rannazzisi tells the inside story of how, he says, the opioid crisis was allowed to spread aided by Congress, lobbyists, and a drug distribution industry that shipped, almost unchecked, hundreds of millions of pills to rogue pharmacies and pain clinics - providing the rocket fuel for a crisis that, over the last two decades, has claimed more than 200,000 lives. JOE RANNAZZISI: This is an industry that's out of control. What they wanna do, is do what they wanna do, and not worry about what the … [Read more...] about Ex-DEA agent: Opioid crisis fueled by drug industry and Congress
For Christophe Weber, the boss of Japan’s Takeda Pharmaceutical, securing a $62bn (€52bn) deal last week to buy drugmaker Shire at the fifth time of asking was the easy bit.Now he has to steer what will be one of the world’s most indebted drugmakers through the big spending cuts needed to make the financial sums work.At the same time, he must win shareholders’ support for the largest-ever overseas purchase by a Japanese company — something he said could be helped by bringing in one or more long-term, large strategic investor. Talks on this were now starting, he said, but declined to identify the parties involved.Shire which employs over 400 people in Dublin and Co Meath had said last year it had plan to grow significantly in Ireland.Mr Weber said in an interview that his prescription for a smooth merger was planning, speed and a surgical focus on culling experimental drugs that fail to offer the high level of medical innovation demanded by cash-strapped … [Read more...] about Shire owner plans spending cuts